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ABSTRACT
Natural antisense transcripts (NATs) are non-coding RNAs that can regulate the
expression of their counterpart protein-coding transcript. While NATs are widespread in
eukaryotic genomes, very little is known about their mechanism. Our study focuses on
gaining a better understanding of the function of NATs in Toxoplasma gondii, a pathogenic
unicellular eukaryote. We recently characterized the gene encoding the first committed
enzyme in SUMOylation, named Ubiquitin-like protease 1 (TgUlp1), and showed that the
expression of TgUlp1 is vital to the life cycle of T. gondii. Interestingly, the locus of
TgUlp1 also transcribes a NAT species. Using a dual luciferase assay and RT-qPCR, we
identified the promoters of TgUlp1 mRNA and NAT and measured their transcript levels
in tachyzoites and bradyzoites. We found that TgUlp1 mRNA and NAT are differentially
regulated at the transcriptional level via promoter activity and transcript turnover.
Furthermore, the products of TgUlp1 NAT processed by RNase III retain the ability to
lower the expression of reporters carrying TgUlp1 mRNA sequences, suggesting the
involvement of RNA interference pathway. In Dicer-knockout (TgDicer-KO) and
Argonaute-knockout (TgAgo-KO) transgenic strains, a higher level of TgUlp1 NAT, and
much lower level of TgUlp1 mRNA was detected, suggesting that Dicer and Ago may be
involved in maintaining TgUlp1 mRNA. Although we were unable to determine the direct
effect of TgUlp1 NAT on mRNA, we showed that the introduction of TgUlp1 NAT by
electroporation negatively affected the level of TgUlp1 mRNA. Consequently, regulation
by TgUlp1 NAT would also affect TgUlp1 protein levels and ultimately the SUMOylation
pathway in T. gondii which plays an important role in host cell invasion and cyst genesis.
However, underlying mechanisms remain to be investigated.
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CHAPTER 1 – LITERATURE REVIEW
1.1

Noncoding RNA
Whole transcriptome analysis has revealed that up to 90% of eukaryotic genomes

are transcribed [1]. However, only 1–2% of the transcripts are protein coding. Majority of
the remaining ~98% of transcripts are functional non-protein-coding RNA (ncRNA)
molecules. ncRNAs play an important role in cellular processes, including gene imprinting,
differentiation and development, antiviral response, apoptosis, cell cycle control and more
[2, 3].
1.2

Classification of ncRNA
ncRNA can be classified by their length. An arbitrary 200-nucleotide threshold is

used to separate short and long ncRNA. To date, the best studied short ncRNA are
microRNA (miRNA) and small interference RNA (siRNA), which regulate gene
expression through the RNA interference (RNAi) pathway. Long ncRNAs (lncRNAs) are
larger than 200 nts and can be over 100,000 nts in length. LncRNAs make up the largest
portion of ncRNA and are highly diverse in structure and function [3]. LncRNAs are
detected in the genomes of animals, plants, yeast, prokaryotes and even viruses. However,
they are poorly conserved when compared to well-studied short ncRNAs like miRNAs or
siRNAs [4].
LncRNAs are further classified based on their origin within the genome, including
their location and orientation (Figure 1.1). Intergenic lncRNA are transcribed from the
location between two genes, regardless of their orientation. Intronic lncRNAs are
transcribed entirely from introns of protein-coding genes. Sense lncRNAs are transcribed
from the sense strand of protein-coding genes and overlap the exons. Antisense ncRNAs
1

are transcribed from the antisense strand of protein-coding genes, and also referred to as
natural antisense transcripts (NAT).

(A) Intergenic
Gene 1

ncRNA

Gene 2

(B) Intronic
Exon 1

Exon 2

ncRNA

(C) Sense
ncRNA

Exon 2

Exon 1

(D) Antisense
5’
3’

Figure 1.1

Gene
ncRNA

3’
5’

Classification of Noncoding RNAs by Their Origin

ncRNAs can be classified into four types according to their position in the genome. Green
bars/arrows represent the transcription region and direction of sense transcript and the red
bars/arrows represent the transcription region and direction of the ncRNA. Modified from
[3].
(A) Intergenic ncRNAs are transcribed from the genomic sequences located between two
genes, regardless of their orientation.
(B) Intronic ncRNAs are derived entirely from the introns of protein encoding genes.
(C) Sense lncRNAs are transcribed from the sense strand of protein-coding genes and
overlap with exons of the gene.
(D) Antisense lncRNAs are transcribed from the antisense strand of protein-coding genes.
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1.3

Natural Antisense Transcripts
NATs are widespread in eukaryotes and are recognized as important regulators of

gene expression. Up to 72% of transcriptional units in mice and 22 - 40% in human
(depending on cell type) are transcribed in both orientations, and comparable numbers have
been suggested for other eukaryotes [5, 6]. Similar to mRNA, NATs are capped, polyadenylated, and spliced [3]. Their transcription is also controlled by promoters and
enhancers and transcribed by RNA polymerase II. Unlike mRNAs, NATs preferentially
accumulate in the nucleus, in addition to other cellular compartments, such as mitochondria
[7]. NAT can be broadly grouped into two categories based on the location of their target
as cis- and trans-NATs.
1.4

Cis-NATs
Cis- NATs have been extensively studied in many eukaryotes and found to play a

variety of regulatory roles. They are transcribed from the same genomic locus as their target
but from the opposite DNA strand. Therefore, cis-NATs have perfect base-pairing to their
target transcript. This RNA-RNA interaction can result in translational inhibition, mRNA
degradation, or promote RNA stability [8].
There are three types of cis-NATs based on their position relative to the position of
their target gene (Figure 1.2). In head-to-head orientation, the sense and antisense
transcripts overlap on their 5’-end. In addition, the 5’-UTR of the sense gene may harbour
a bidirectional promoter capable of initiating transcription for both sense and antisense
transcripts. Tail-to-tail describes transcripts overlapping at the 3’-ends. In full overlap,
NAT completely overlaps with the sense transcript. The transcription starts site (TSS) of

3

NAT occurs within the sense gene, resulting in high level of complementarity between the
sense and antisense transcript.

(A) Head-to-head

(B) Tail-to-tail

(C) Full (embedded) overlap

5’

3’

3’

5’

5’

3’

3’

5’

5’

3’

3’

5’

Figure 1.2
Classification of Cis-NATs Based on Their Orientation Relative to
Their Target Gene
Cis-NATs can be classified into three types according to their positions relative to the sense
counterpart. Green bars represent the transcription region of the sense transcript, and the
red bars represent the transcription region of the antisense transcript. Arrows represent
transcription start site (TSS) and direction of transcription. Modified from [3].
(A) Head-to-head: the sense and antisense transcripts overlap on their 5’-ends.
(B) Tail-to-tail: sense and antisense transcripts overlap on their 3’-ends.
(C) In a full overlap (or embedded overlap), the NAT transcription region is totally
included within the sense transcription region.
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1.5

Regulatory functions of Cis-NATs

Cis-NATs exert their activity through various mechanism including transcription
interference, chromatin modification, RNA editing, and RNA masking.
1.5.1 Transcriptional Interference
Transcriptional interference refers to the suppression of one transcriptional process
by the direct influence of a second transcriptional process. The close proximity of the cisNAT transcriptional unit to the target transcriptional unit makes it possible for gene
regulation to occur without the direct pairing of the RNA molecules themselves. Four
mechanisms of transcriptional interference that affect sense and antisense gene pairs have
been hypothesized (Figure 1.3) [9].
(i) Promoter Competition: A sense and antisense gene pair in a head-to-head
orientation will share a bidirectional promoter that initiates transcription in both
orientations. During the initiation phase, steric hinderance and competition for the binding
of RNA Polymerase II (RNAP) and other transcriptional elements can occur for
bidirectional promoter. This restricts the RNAP binding to one promoter, enhancing its’
activity and leads to the downregulation of the other transcript. Over 7000 sense and
antisense transcript pairs were identified in the human genome and found that 76% exhibit
a head-to-head formation, sharing a bidirectional promoter, and within this 58% of NATs
begin from a 500 bps region upstream of the TSS of the sense gene [10].
(ii) Sitting Duck Mechanism: An RNAP complex that is too slow to transition form
open to an elongation complex is considered a ‘sitting duck’, which can be dislodged by
an elongating RNAP from a different promoter downstream.

5

(iii) Occlusion: Occlusion occurs when an elongating RNAP is passing through a
promoter, therefore blocking the binding of another RNAP. However, transcription
elongation occurs rapidly in most organisms, meaning that occlusion is very brief, so even
extremely strong interfering promoters will not produce much occlusion by elongating
RNAP [11].
(iv) RNAP Collision: When both sense and antisense transcription has already
initiated, the collision of both RNAP complexes during elongation phase can lead to the
premature termination of one of the complexes. As elongating RNAP envelops both strands
of DNA, it is likely that both RNAP cannot continue transcription past one another. RNAP
collisions have been imaged by atomic force microscopy, showing that one elongating
RNAP forces the opposing RNAP to stall and backtrack [11].

6

RNAP

pSen

(A) Promoter Competition

(B) Sitting Duck Interference

pAS

pSen

pSen

pAS

pAS

(C) Occlusion

(D) RNAP Collision

Figure 1.3

pSen

pAS

Mechanisms of Transcriptional Interference

Promoters of sense genes are represented as green boxes (pSen), and promoters of antisense
genes are represented red boxes (pAS). Green and red arrows represent direction of
transcription for sense and antisense transcription respectively. Rounded triangles
represent RNA Polymerase II (RNAP). Modified from [9].
(A) Promoter Competition: In the initiation phase, promoters of head-to-head NATs
compete for the RNAP and regulatory elements.
(B) Sitting Duck Mechanism: RNAP that is too slow to start is dislodged by an elongating
RNAP.
(C) Occlusion: Elongating RNAP is passing through a promoter, therefore blocking the
binding of another RNAP.
(D) RNAP Collision: In the elongation phase, collision between RNAP can lead to a
transcriptional interference.
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1.5.2 Chromatin Modification
Cis-NATs can regulate gene expression through epigenetic mechanisms. A classic
example is X chromosome inactivation by X-inactive specific transcript (XIST). XIST is
expressed from a region of chromosome X called the X inactivation center (XIC). XIST
transcriptionally silences one of the pairs of X chromosomes in early developmental
process in mammalian females to provide dosage equivalence between males and females.
XIC also expresses a cis-NAT called Tsix, which silences XIST by directing modification
of the chromatin structure [12].
Cis-NATs also influence DNA methylation. DNA methylation is a fundamental
epigenetic mechanism that regulates gene transcription. It involves the addition (or
removal) of methyl group to cytosines that are typically found in CpG-rich regions of
genome, referred to as CpG islands. CpG islands are often found at promoters and first
exons regions [13]. At unmethylated CpG islands, transcription of the gene is possible; at
methylated CpG islands the transcription of the gene is blocked. Cis-NATs have been
implicated in both methylation and demethylation of DNA to regulate gene expression. For
example, the cis-NAT of Hemoglobin, alpha 2 (HBA2) mediates methylation CpG island
in the promoter for HBA2, resulting in in gene silencing [14]. Conversely, NAT can also
be responsible for DNA demethylation to increase transcription. An example is the NAT
for the tumor suppressor TCF21, which facilitates demethylation of the TCF21 promoter,
leading to its expression [15].
1.5.3 RNA Editing
RNA editing is an enzymatic reaction catalyzed by adenosine deaminases that act
on RNA (ADARs) that converts adenosines (A) into inosines (I). ADARs target dsRNA
8

such as those formed by sense and antisense transcripts [16]. After A-to-I editing, inosine
is interpreted as guanine during splicing or translation. Such modification may control the
localization or the stability of the edited transcripts. For example, the pre-mRNA of
PRUNE2 and its overlapping NAT named PCA3, creates a dsRNA that forms a complex
with ADAR proteins. This leads to A-to-I editing of PRUNE2 transcript, resulting in
protein downregulation and increase in tumor cell growth [17].
1.5.4 RNA Masking
RNA masking refers to the formation of a sense and antisense dsRNA which
provides protection against post-transcriptional regulation factors that target the gene. This
provides physical protection by interfering with splicing and translation machineries. For
example, the expression of the transcription repressor Zeb2 is dependent on RNA masking
done by its NAT. When the 5′-UTR of Zeb2 mRNA is spliced, it disrupts the sequence for
the internal ribosome entry site (IRES) required for translation. Therefore, Zeb2 mRNA is
no longer able to bind ribosomes and translate the protein. When the Zeb2 NAT sequence
overlaps the 5’-UTR, it prevents the binding of the spliceosome to the 5′ splice site.
Consequently, the IRES is conserved and Zeb2 protein is translated [18].
Conversely, sense and antisense transcript binding may also lead to degradation of
a transcript, such as in the case of MALAT1, a nuclear-retained long noncoding RNA that
promotes malignancy. The NAT of MALAT1, named TALAM1, binds the 3’-UTR of
MALAT1 and allows for cleavage by RNase P. This leads to 3’-end processing and
maturation that is essential for MALAT1 stability and function [19]. RNA masking also
prevents miRNA and siRNA from binding as well as protect transcripts from RNAses
which target single stranded RNA [20, 21].
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1.6

Trans-NATs
Trans-NATs are transcribed from a different location than their targets and could

have complementarity to multiple transcripts with mismatches. Although there are very
few studies on long trans-NATs, in silico analysis have identified trans-NATs in
abundance in many eukaryotes such as humans, mice, plants, zebrafish, flies, and worms
[22].
There is various evidence to suggests that trans-NATs perform diverse regulatory
functions. For example, the 2.2-kb NAT transcribed from the HOXC gene cluster on
chromosome 12, called HOX antisense intergenic RNA (HOTAIR) is capable of
modifying histones to regulate gene expression. HOTAIR directly interacts with Polycomb
Repressive Complex 2 (PRC2) with its 5’-end to induce tri-methylation on histone H3,
lysine 27 and interacts with lysine-specific histone demethylase 1A (LSD1) on its 3’-end
to induce demethylation on histone H3, lysine 4. These combined modifications, performed
in trans on chromosome 2, leads to a repressive chromatin structure, thus silencing of
multiple genes [23]. Long trans-NATs have also been implicated in mRNA degradation
and translational repression [24].
1.7

ncRNA and RNA Interference
RNA interference is a biological process specific to eukaryotes, in which short

ncRNA (~22 nts) called siRNA and miRNA inhibit gene expression. Formation of
si/miRNA requires dsRNA precursors to be cleaved by Dicer, an RNase III enzyme.
Studies have shown that NAT can serve as a dsRNA precursor needed for si/miRNA
formation [25, 26]. dsRNA created by internal hairpins loops in NATs can be digested by
Dicer to form NAT-miRNA. NAT can form long dsRNA with its sense transcript which is
10

digested by Dicer to produce NAT-siRNA. After digestion by Dicer, NAT-si/miRNA is
bound to Argonaute (Ago) and integrated into the RNA-induced silencing complex (RISC).
NAT-si/miRNA guides Ago to target mRNA molecules for silencing or degradation based
on complementary sequence [27]. NAT-siRNA forms perfect base pairs with their target
mRNA and can act in cis to downregulate the sense gene expression [28]. On the other
hand, NAT-miRNA forms imperfect base pairs with target mRNA, allowing it to act in
trans to regulate multiple genes.
1.8

NATs in Apicomplexa
Majority of the studies on NATs have been focused in humans; very little is known

about NATs in Apicomplexa, a phylum of eukaryotic unicellular organisms that consist of
numerous pathogenic parasites of human and domestic animals. Plasmodium falciparum,
which causes malaria, is responsible for millions of deaths each year in the developing
world. Eimeria spp. and Cryptosporidium spp. are important enteric pathogens in humans
while Neospora spp. and Theileria spp. are veterinary pathogens. Toxoplasma gondii and
Cryptosporidium parvum have caused water-borne disease outbreaks [29].
In Plasmodium, NATs are very frequent and associated with ~24% of all open reading
frames [30]. A high frequency of antisense RNAs was also observed in T. gondii [31].
Radke et al., [31] used serial analysis of gene expression (SAGE) to examine the T.
gondii transcriptome and reported ~21% of antisense transcription. Both Plasmodium and
T. gondii also show an inverse relationship between the frequency of antisense transcripts
and the level of sense transcription [31]. To date, there is no information regarding NAT
regulation, function, or its implications in cell biology in T. gondii.
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1.9

Toxoplasma gondii, the Model Apicomplexan
In contrast to bacterial pathogens, apicomplexan parasites are eukaryotic and share

many metabolic pathways with their hosts. This makes therapeutic target development
extremely difficult – a drug that harms an apicomplexan parasite is also likely to harm its
host. Research on these parasites is challenging because it is difficult to maintain live
parasite cultures in the laboratory and to genetically manipulate these organisms. However,
T. gondii is both easily cultured in the lab and readily amenable to genetic manipulation.
This allows researchers to study many biological or biochemical functions of proteins in
T. gondii that cannot be done in other apicomplexans. Studies are readily performed in T.
gondii due to the high efficiency of transient and stable transfection and the availability of
many cell markers. While results in T. gondii might not always be applicable to other
Apicomplexa due to differences between the parasites, T. gondii remains an important
model system for understanding the biology of apicomplexan parasites [32]
1.10 Discovery of Toxoplasma gondii
In 1908, Nicolle and Manceaux were studying the tissue of the rodent
Ctenodactylus gundi and found a parasite they believed to be Leishmania. However, they
realized they had discovered a new parasite species and named it Toxoplasma gondii due
to its crescent morphology; toxo meaning “bow” and plasma meaning “creature” [33]. T.
gondii is an obligate protozoan parasite belonging to the phylum Apicomplexa. Most
apicomplexans are characterized by a unique organelle called an apicomplast, which
perform essential metabolic functions for the viability of the parasites [34]. They also have
complex life cycles alternating between sexual and asexual cycles in different hosts.
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T. gondii can infect any nucleated mammalian or avian cell, including humans,
causing toxoplasmosis. An estimated 15 to 85% of the world adult human population is
chronically infected with T. gondii, depending on geographical location [35]. In infected
individuals with healthy immune systems, T. gondii infection is asymptomatic. In
immunocompromised individuals, the infection can result in serious illness and death.
1.10.1 Life cycle of T. gondii
T. gondii goes through a sexual cycle within definitive hosts and an asexual cycle
within intermediate hosts. The parasite exists in three forms: sporozoites, tachyzoites, and
bradyzoites. Oocysts – containing sporozoites – are only produced by sexual reproduction
in the definitive host, felines, and passed in feces which are then ingested by intermediate
hosts such as humans (Figure 1.4). The asexual cycle continues in the intermediate host.
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Life Cycle of Toxoplasma gondii in Definitive and Intermediate Hosts

T. gondii undergoes a sexual cycle in the definitive host to produces oocysts that are
excreted through feces into the environment. Oocysts are ingested by intermediate hosts
where the parasite undergoes asexual cycle. Initial infection by tachyzoites is acute. Once
the host organism triggers an inflammatory response, tachyzoites are forced to convert to
bradyzoites to become latent. When the host organism becomes immunocompromised,
bradyzoites convert back to tachyzoites to cause recurrent infection. Modified from [32].
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1.10.2 Asexual Life Cycle
Nicolle and Manceaux found T. gondii in its tachyzoite forms, also known as its
proliferative form. Tachyzoites infect and grow through a process called the lytic cycle
(Figure 1.5). First, T. gondii infects a host cell by attaching to and penetrating the cell
membrane using gliding motility. Once inside the host cell, the parasite is enclosed in the
parasitophorous vacuole (PV) in the host cell cytoplasm. The PV is derived from the host
cell membrane as well as lipids and proteins from the parasite [36]. Inside the PV, the
parasite divides asexually every 6-9 hours through a process called endodyogeny in which
two daughter cells are produced within the mother cell, which is then consumed by the
offspring prior to their separation [37]. The host cell ruptures when it can no longer support
the growth of tachyzoites, and parasites move on to infect the next available cell.
Destruction of host cells by tachyzoites growth triggers the host’s immune
response. In response to this environmental stress, tachyzoites convert to bradyzoites, also
known as the slowly dividing form of the parasite. Bradyzoites are enclosed in tissue cysts
that have a glycosylated cyst wall, made up of host and parasite materials that protects the
parasite from the host immune system. Tissue cysts are most prevalent in neural and
muscular tissues, including the brain, eyes, and skeletal and cardiac muscles [37]. Tissue
cysts can persist for the life of the host without triggering an immune response, causing
chronic infection. If the host organism becomes immunocompromised, the bradyzoites can
differentiate back into the tachyzoite form and can cause damage in the host [37].
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Lytic Cycle

Figure 1.5

T. gondii Asexual Life Cycle Within A Host Cell

Asexual cycle in intermediate host cells results in proliferation of T. gondii through the
lytic cycle to produce tachyzoites. Tachyzoites attach and penetrate through the cell
membrane. In the cytoplasm, the tachyzoite is enclosed in a parasitophorous vacuole where
it replicates intracellularly by endodyogeny. The host cell ruptures when it can no longer
support the growth of tachyzoites within it and parasites move on to infect the next
available cell, completing the lytic cycle. Stress can force tachyzoite into bradyzoites,
which are enclosed in a tissue cyst. Bradyzoites continue to replicate by endodyogeny but
much slower. When the host organism becomes immunocompromised, bradyzoites convert
back to tachyzoites. Modified from [38]. .
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1.10.3 Toxoplasmosis and Treatment
Toxoplasmosis can be acquired congenitally and by ingesting infected meat or
water contaminated with oocysts, which are shed in the feces of infected cats. Acute
toxoplasmosis, caused by tachyzoites in the lytic phase, can manifest with flu-like
symptoms including swollen lymph nodes, headaches, fever, fatigue, or muscle aches [39].
Immunocompetent individuals can suppress the acute infection and become latent
(asymptomatic). However, once individuals become immunocompromised, they are at risk
of recurrent toxoplasmosis which can cause serious illness. This includes damage to the
central nervous system causing speech abnormalities, motor deficits, seizures, psychosis,
and is potentially fatal if left untreated [40].
Toxoplasmosis is usually asymptomatic; thus, treatment of the infection is limited
only to individuals showing signs of acute infection, newly infected pregnant mothers, or
preventative treatment for individuals at high risk of recurrent toxoplasmosis [40].
Standard treatment for toxoplasmosis includes a combination of sulfadiazine and
pyrimethamine [40]. Despite their effectiveness, these drugs can only target tachyzoites
and have no effect on the remaining tissue cysts. They also have serious side effects;
pyrimethamine is associated with bone marrow toxicity and sulphadiazine with allergy,
making these drugs unsuitable for long term treatment [33].
1.10.4 T. gondii Clonal Lineages
Three clonal lineages of T. gondii have been identified; type I, type II and type III
[41]. Genomic analysis indicates the clonal lineages differ by only 1–2% at the nucleotide
level. All three strains can infect their intermediate host orally, bypassing the need for the
sexual stage of the parasitic life cycle which limits genetic recombination and the formation
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of a wider range of genotypes. Furthermore, infection in intermediate hosts by multiple
strains is rare, therefore recombinant genotypes are unlikely to emerge [42].
Although there is no significant difference at the genomic level, studies in mice
have shown differences in pathogenesis among the different clonal lineages. Type I strain
is highly virulent in comparison to type II and III strains [43]. However, studies in North
America and Europe has identified type II strains as the most prevalent cause of human
toxoplasmosis in congenital and AIDS patients, while type III is largely confined to
animals [44].
1.11 Post-Translational Regulation by SUMOylation
SUMOylation refers to the reversible addition of a small protein named small
ubiquitin-like modifier (SUMO) to a protein substrate. SUMO has significant homology
to ubiquitin, a highly conserved modifier protein found in all eukaryotic cells. SUMO and
ubiquitin share a similar three-dimensional structure, yet less than 20% amino acid
sequence similarity [45]. They also share a very similar pathway in conjugating to their
protein substrates. However, while ubiquitinated proteins are generally targeted for
degradation, SUMOylated proteins are regulated for different functions within a cell.
Studies suggest that SUMOylation is involved in many aspects of cell function such as
DNA damage repair, maintenance of genome integrity, transcription regulation, and
nuclear transport [46]. The SUMO protein is translated as a precursor peptide, around 100
amino acids. It has been evolutionary conserved exclusively in eukaryotes. In higher
eukaryotes such as mammals and plants, there can be up to as many as eight SUMO
isoforms [47].
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SUMOylation is initiated by the C-terminal cleavage of extra amino acids in the
precursor SUMO peptide by a protease named Ubiquitin-like protease 1 (Ulp1) (Figure
1.6A). Ulp1 is a cysteine peptidase that is highly specific for the SUMO peptide, as it
recognizes the tertiary structure of SUMO rather than an amino acid sequence [48].
Cleavage of the SUMO precursor reveals a di-glycine motif that will ultimately be linked
to lysine side chains in target protein substrate. After cleavage, the SUMO protein is
activated by the E1 activating enzyme. This involves the formation of adenylated SUMO
at the C-terminal carboxyl group of SUMO (Figure 1.6B). The SUMO-AMP bond breaks
and is followed by the formation of a thioester bond between C-terminal carboxyl group of
SUMO and cysteine residue in E1 activating enzyme (Figure 1.6C) [49]. Next, SUMO is
transferred to E2 conjugating enzyme which binds the target protein. SUMO is then
conjugated to the target protein by E3 ligase enzyme that recognizes the ψKxD/E consensus
sequence (where ψ is a large hydrophobic residue and x is any residue) [50]. The carboxyl
group of the di-glycine motif is ligated to the ψ–amino group of a lysine residue on the
substrate (Figure 1.6D). Ulp1 is also responsible for the removal of SUMO from
SUMOylated proteins (Figure 1.6E) [48].
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GG
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D. Ligation

Figure 1.6

B. Activation

C. Transesterification

The SUMOylation pathway

The SUMOylation pathway is initiated by the cleavage of a SUMO precursor at the Cterminal end to reveal a diglycine motif by Ulp1 (A). The mature SUMO is transferred to
an E1 then E2 complex (B, C). E3 ligates SUMO to a protein substrate (D), which
recognizes the ψKxD/E consensus sequence (where ψ is a large hydrophobic residue and
x is any residue). Ulp1 also removes SUMO from conjugated protein substrates (E).
Modified from [51].
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1.11.1 SUMOylation in T. gondii
Only one gene is encoded for SUMO in lower eukaryotes, including T. gondii and
other Apicomplexans [52]. Braun et el., [52] characterized the SUMOylation pathway in
T. gondii. They determined that the TgSUMO knockout or overexpression by a strong
promoter was determined to be lethal. They identified 120 putative SUMOylated proteins.
This revealed SUMOylation to be involved in many diverse cellular processes such as
metabolism, protein translation and folding, signalling, transport and more. After
developing an antibody against recombinant TgSUMO, they used it to localize free SUMO
and SUMOylated proteins in the parasite. They observed that TgSUMO was present at the
tachyzoite membrane at the point of contact during invasion. Once successfully invaded,
TgSUMO was localized to the parasite nucleus. In bradyzoites, they observed TgSUMO at
the PV membrane that encapsulates the parasite within the host cell. All of this is indicative
of the important role that SUMOylation plays during host cell invasion and survival of the
parasite.
1.11.2 Ubiquitin-like protease 1 in T. gondii
Crater et al., [53] characterized the T. gondii homolog of ubiquitin-like protease
and named it TgUlp1. They found that TgUlp1 is negatively regulated by Tg-miR60, an
abundant miRNA species in T. gondii type I strain. Misregulation of TgUlp1 is detrimental
to the parasite, indicating its essential role in the parasite’s life cycle. Surprisingly, they
also discovered a NAT transcribed from the same locus and referred to it as TgUlp1 NAT.
TgUlp1 NAT was detected by RT-PCR to be transcribed from the intron 6/7 region of
TgUlp1 (Figure 1.7). Due to the complementary sequence between TgUlp1 mRNA and
NAT, it was hypothesized that the expression of TgUlp1 mRNA is self-regulated by
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TgUlp1 NAT. This would be the first example of a self-regulating gene identified in T.
gondii.
1.12 Research Hypotheses and Objectives
The objective of my study is to gain a better understanding of the mechanism
controlling the expression of NAT, using T. gondii as a model organism. I aim to identify
the elements controlling the expression of TgUlp1 NAT and elucidate its mechanism of
function. The specific aims are as follows:
(I)

To identify the promoter controlling the expression of TgUlp1 mRNA and

NAT, I will use a dual luciferase assay. It is hypothesized that the promoter for TgUlp1
mRNA would lie upstream from exon 1 on the sense strand, and the TgUlp1 NAT would
lie upstream from intron 7 on the antisense strand (Figure 1.7). If putative promoter
sequences are capable of initiating transcription, it will successfully drive the expression
of RnLuc reporter protein which can be quantified.

Figure 1.7

TgUlp1 Locus

TgUlp1 has 13 exons indicated as black boxes and 12 introns indicated as numbered white
boxes. Dotted areas are the presumed 5’- and 3’-regions flanking TgUlp1 CDS. Green
arrow represents mRNA transcription direction and TSS. Red arrow represents NAT
transcription direction and TSS. Green and red dotted lines indicate the location of putative
promoters for mRNA and NAT, respectively.
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(II)

To characterize the expression pattern of TgUlp1 mRNA and NAT between

tachyzoites and bradyzoites, I will perform RT-qPCR. Many studies have documented
genes that are differentially expressed in either tachyzoites or bradyzoites, suggesting that
differential gene regulation plays a major role in coordinating stage conversion in T. gondii.
My study will provide more insight into the role of NATs in gene expression and stage
conversion in T. gondii.
(III)

To determine the regulatory role of TgUlp1 NAT, I will use a dual luciferase

assay. TgUlp1 mRNA has eleven predicted Tg-mir60 family binding sites [53]. When three
sites were tested with mir60a – a member of Tg-mir60 family – only one of these sites were
downregulated, and the other two were unaffected. These sites might be downregulated by
other members of mir60, such as those derived from TgUlp1 NAT. TgUlp1 NAT
transcription region overlaps from intron 6 to intron 7, making it possible to form dsRNA
with the mRNA. TgUlp1 NAT secondary structure also contains many hairpin structures.
Thus, it is hypothesized that both these dsRNA and hairpin structures could serve as
precursors of siRNA and miRNA for RNAi.
(IV)

To investigate the involvement of key enzymes, Dicer and Ago, of RNAi

in the expression of TgU1p1 transcripts, RT-qPCR will be performed in Dicer knockout
(TgDicer-KO) and Ago knockout (TgAgo-KO) strains. The RNase III activity of Dicer and
ribonuclease activity of Ago will be required for the processing and function of TgUlp1
NAT. Therefore, changes in TgUlp1 mRNA expression in the transgenic strains will
implicate RNAi in the function of TgUlp1 NAT.
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CHAPTER 2 – MATERIALS AND METHODS
2.1

Cell and Parasite Culture
2.1.1

Mammalian cell culture

Human foreskin fibroblasts (HFF, ATCC-1041) grown and maintained in
Dulbecco’s Modified Eagle Medium (DMEM) with high D-glucose and L-glutamine
(Invitrogen, #12100046) supplemented with 10% cosmic calf serum (ThermoFisher
Scientific, Hylcone, # SH30087.03), and 5 μg/ml antibiotic-antimycotic (Invitrogen, #
15140-122) at 37 °C in 5% CO2.
2.1.2

Toxoplasma gondii culture

Confluent monolayers of HFF were infected with T. gondii. The infected monolayer
is maintained using Minimum Essential Medium (MEM, Invitrogen, #61100061)
supplemented with 1% (v/v) fetal bovine serum (FBS, Sigma) and 5 μg/ml antibioticantimycotic (Invitrogen, #15240-062) incubated at 37 °C in 5% CO2. Type I and Type II
strains of T. gondii (NIH-AIDS Reagent Program, #2859 and #2858) were maintained in
media without selection. TgAgo-KO strain was obtained from Dr. Boothroyd, Stanford
University School of Medicine and also maintained in media without selection. TgDicerKO was created by Farzana Afrin and maintained in selection media containing
mycophenolic acid (25 μg/mL) and xanthine (50 μg/mL).
2.2

Construction of Plasmids for Promoter Reporter Assays
Primers used for plasmid construction are listed in Table B1. Putative promoter

sequences were amplified by PCR using Type I genomic DNA as template and performed
following the manufacturer’s protocol (Phire Hot Start II DNA Polymerase, #F122S). The
PCR reaction tubes were placed in the 96-well BioRad T100TM Thermal Cycler for 35
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cycles. Three overlapping regions upstream from exon 1 were amplified from the sense
strand using primers a, b, c and d to give amplicons of 500, 1135 and 2518 bps,
respectively. Four overlapping regions downstream from intron 1 were amplified from the
antisense strand using primers e, f, g, h, and i to give amplicons of 529, 1167, 2159, and
2670 bps respectively. Amplified fragments were purified by gel extraction using the
QiaexII Gel Extraction kit (Qiagen, #20021) following the manufacturer's protocol and
used as inserts in ligation reactions. pTUBRnLuc was digested with NheI and HindIII to
remove the tubulin (TUB) promoter (2717bps). The linearized pTUBRnLuc plasmid
(6071bps) was purified using QiaexII Gel Extraction kit (Qiagen #20021) following the
manufacturer's protocol and used as a vector in ligation reactions. The ligation reaction was
performed using the Cold Fusion Cloning Kit (System Biosciences, #MC010A-1) or
NEBuilder HiFi DNA Assembly Master Mix (New England Biolabs, Inc., #E5520S)
following the manufacturer's protocol. Resultant plasmids carry putative promoters
upstream from RnLuc coding sequence which would drive RnLuc transcription. Plasmids
were subjected to restriction endonuclease analyses to confirm their identity before being
used in the dual luciferase assay.
2.3

In vitro transcription of TgUlp1 NAT
2.3.1

Generating Template with T7 Promoter

Primers used for plasmids construction are listed in Table B3. PCR was performed
using OneTaq® Quick-Load® 2X Master Mix (New England Biolabs, Inc., #M0485S)
according to the manufacturer’s protocol to generate DNA templates for the synthesis of
single- and double-stranded RNA with the sequence encompassing intron 6 and 7 regions
of TgUlp1 (1,167 bps). T7 promoter sequence was incorporated onto the reverse primer
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was used to generate single stranded TgUlp1 NAT (ssNAT). T7 promoter sequence on both
primers was used to generate double stranded TgUlp1 NAT (dsNAT).
2.3.2

In vitro transcription of NAT

PCR products were used as a template for T7 transcription. In vitro transcription
reactions were carried out in 50 μL reaction mixtures in the presence of T7 RNA
polymerase (~5 units), 80 mM HEPES-KOH, pH 7.5, 24 mM NaCl, 2 mM spermidine, 40
mM DTT, 10 mM rNTPs, and ~1 unit pyrophosphatase at 37 °C for 16 hours. Reactions
were subsequently extracted with one volume of phenol-chloroform mixture (1:1), and
resultant RNAs were precipitated and quantified (Thermo Scientific NanoDraop2000).
2.3.3

Preparation of Small RNA

In vitro transcribed TgUlp1 NAT was treated with ShortCut RNase III prior to
transfection for dual luciferase assay according to manufacturer’s protocol (New England
Biolabs, Inc., #M0245S). The products were checked by PAGE analysis.
2.3.4

PAGE Analysis

RNase III digestion products of in vitro transcribed TgUlp1 NAT were suspended
in formamide 2X buffer and separated on a 12.5% denaturing urea gel. The gel was stained
for 30 minutes with SYBR Gold Nucleic Acid Gel Stain (ThermoFisher Scientific,
#S11494) in TBE buffer and imaged using BioRad Molecular Imager FX.
2.4

Electroporation
Freshly lysed parasites were harvested and used for transfection via electroporation

using a BTX ECM 630 (1500 volts, 25 Ω, and 25 μF). For each electroporation, 2 µg of
FFLuc plasmid and varying amounts of RnLuc plasmids were mixed with harvested
parasites in 400 μL of electroporation mixture (120 mM KCl, 0.15 mM CaCl 2, 10 mM
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K2HPO4/KH2PO4 (pH 7.6) 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione).
Table B5 lists the type and amount of plasmid electroporated depending on experiment.
Following electroporation, the parasites were allowed to infect confluent HFF monolayers
and grown under different conditions depending on the experiment.
2.5

Dual Luciferase assay
Parasites were grown under testing conditions (24 hours under neutral pH, 5% CO2,

or up to 72 hours under alkali conditions, atmospheric CO2 conditions). The parasites were
harvested and lysed with 100 μL of 1x Passive Lysis Buffer (Promega, #E1531) and
incubated for 15 minutes at room temperature. Lysates were cleared of debris by
centrifugation (12,000 x g for 1 minute) and used in the dual luciferase assay, which was
carried out in a 2-step fashion. To measure FFLuc activity, 20 μL of lysate was added to a
freshly made reaction mixture (100 μL) containing 200 μM D-luciferin, 20 mM Tricine,
10 mM MgSO4, 5 mM DTT, 250 μM ATP and 250 μM Coenzyme A. The mixture was
incubated for 5 seconds at room temperature and luminescence was measured with a
20/20n Luminometer (Turner Biosystems). For RnLuc assay, 20 μL of lysate was added to
a freshly made reaction mixture (100 μL) containing 0.1 μM Coelenterazine, 100 mM
K2HPO4/KH2PO4 (pH 7.6) 500 mM NaCl, 1 mM EDTA, and 0.02% BSA. The mixture
was incubated for 5 seconds at room temperature and luminescence measured with a
20/20n Luminometer (Turner Biosystems). RnLuc activity were normalized to FFLuc
activity for a direct comparison across independent experiments. Three independent
experiments were performed for every dual luciferase assay.

27

2.6

RT-PCR Analysis
2.6.1

RNA Isolation

Total RNA was isolated from freshly lysed parasites using TriReagent (Molecular
Research Center, #TR 118) and treated with RQ1 RNase free DNase (Promega, #M6101)
following manufacturer's protocol. Treated RNA was extracted with one volume of phenolchloroform mixture (1:1) three times, and resultant RNA was precipitated and quantified
(Thermo Scientific NanoDraop2000). Integrity of the RNA was determined by gel
electrophoresis on 1% agarose gel. Samples were stored at −20 °C for future use.
2.6.2

Reverse Transcriptase

First strand cDNA synthesis was performed using ~500 ng isolated total RNA. The
reaction was performed using Moloney Murine Leukemia Virus Reverse Transcriptase (MMLV RT) (New England Biolabs, Inc., #M0253S) following the manufacturer's protocol.
A negative control reaction in the absence of M-MLV was performed at the same time.
Samples were stored at −20 °C for future use.
2.6.3

RT-qPCR

The cDNA reaction mixtures were diluted 1/1000 dilution for tachyzoite samples
and 1/10 dilutions for bradyzoite samples and analyzed by using Fast EvaGreen® qPCR
Master Mix (2x) (Cat #31003) and OneStepPlus thermocycler (Applied Biosystems)
following the manufacturer’s protocol. Primers used for RT-qPCR are listed in Table B4.
Relative TgUlp1 mRNA and NAT expression levels in comparison to GAPDH expression
levels were measured and calculated using 2-ΔΔCt protocol. RT-qPCR were analyzed using
both biological and technical triplicates.
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2.7

Immunofluorescence Assay
Cells were fixed in 3% paraformaldehyde in PBS for 10 minutes, permeabilized

with 0.25% Triton X-100 in PBS for 15 minutes, and non-specific sites were blocked with
5% equine serum in PBS for 1 hour at room temperature. Slides were incubated for 1 hour
with FITC-conjugated Dolichos biflorus lectin (1:300, L9142, Sigma) to stain cyst walls
formed under bradyzoite culturing conditions. Staining of the nuclei was carried out by
incubation in the presence of Hoechst 33342 solution (3 µM). All images were taken with
Leica DMI 6000B inverted fluorescent microscope using HCX PL Apo 40x/1.40-0.70
objective and a Leica DFC 360FX camera in addition to the Leica Application Software
(LAS).
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CHAPTER 3 – RESULTS
3.1

Establishing a Dual Luciferase Reporter to Study Promoters
To identify the element(s) controlling the expression of TgUlp1 mRNA and NAT, a

dual reporter assay was used. The term ‘dual’ refers to the use of two individual plasmids
expressing different reporter proteins. For this study, one of the reporter plasmids
constitutively expresses firefly (Photinus pyralis) luciferase under the control of previously
characterized tubulin (TUB) promoter. The activity of FFLuc serves an internal control for
transformation efficiency and expression level. The second plasmid expresses sea pansy
(Renilla reniformis) luciferase, under the control of putative promoter sequences for
TgUlp1 mRNA and NAT. The activity of RnLuc reflects the activity of the regulatory
sequence being investigated. As the region upstream from the first exon of TgUlp1 mRNA
and the region downstream from the intron 7 of TgUlp1 locus were hypothesized to carry
the sense and antisense promoter sequence, three overlapping regions upstream from exon
1 of TgUlp1 mRNA on the sense strand (SS) and four overlapping regions downstream
from intron 7 on the antisense strand (AS) were tested (Figure 3.1). These sequences were
amplified by PCR (Figure 3.2) and placed upstream from the RnLuc CDS (Figure 3.3).
Resultant plasmids were collectively called pPutPromRnLuc (Table B2). The successful
expression of RnLuc by the putative promoter was indicative of the sequences’ ability to
initiate transcription.
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Figure 3.1

Putative Regions Tested for Promoter Activity

Schematic representation of the TgUlp1 locus. TgUlp1 has 13 exons indicated as black
boxes and 12 introns indicated as numbered white boxes. The region upstream from the
first exon of TgUlp1 locus was hypothesized to carry the sense promoter sequence
controlling the transcription of TgUlp1 mRNA (represented by green arrow). Green bars
upstream from the first exon represent putative promoter sequences on the sense strand
amplified and tested for sense promoter activity. The region downstream from the intron 7
of TgUlp1 locus was hypothesized to carry the antisense promoter sequence controlling the
transcription of TgUlp1 NAT (represented by red arrow). Red bars downstream from the
intron 7 represent putative promoter sequences on the antisense strand amplified and tested
for antisense promoter activity. The primers used for PCR analysis and cloning are
indicated by letters and arrows and listed in Table B1.
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Figure 3.2

Representative Gel Image of PCR Analysis of Putative Promoters

Primer sets a-b, a-c, and a-d were used to amplify 0.5-kb, 1.0-kb, and 2.5-kb regions on the
sense strand upstream from exon 1. Primer sets e-g, e-h, f-i and e-i were used to amplify
0.5-kb, 1.0-kb, 2.5-kb and 2.0-kb regions on the antisense strand downstream from intron
7. Amplicons were gel purified and cloned into plasmid construct to control the expression
of RnLuc.
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Plasmid Constructs Used in the Promoter Assays

In the plasmid pTUBRnLuc, the expression of Renilla luciferase (RnLuc) is under the
control of tubulin (TUB) promoter. This plasmid was used as a positive control for an
active promoter. The plasmid pRnLuc lacking a promoter was used as a negative control
for background activity. In the test RnLuc plasmids – collectively called pPutPromRnLuc
– the TUB promoter was replaced with putative promoter sequences from the TgUlp1 locus
from the sense strand (green – 0.5-kb, 1.0-kb, or 2.5-kb) or the antisense strand (red – 0.5kb, 1.0-kb, 2.5-kb, or 2.0-kb). A successful expression of RnLuc by a putative promoter is
indicative of the sequence promoter activity. The plasmid pTUBFFLuc codes for Firefly
luciferase (FFLuc) under the control of a TUB. All RnLuc activities are normalized to
FFLuc activity.
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The activity of pTUBRnLuc was used to establish maximum promoter activity. The
activity of the pRnLuc – no promoter – was used to establish the threshold for background
activity. When equal amounts of pTUBRnLuc and pRnLuc (5 µg) were electroporated and
the activity was compared, we found that the activity of the plasmid with TUB promoter
was approximately 70x greater than no promoter (Table 3.1). This establishes a wide range
over which the activity of putative promoters can be compared.

Table 3.1

RnLuc Activity of Control Plasmids for Promoter Assay

Plasmid

Plasmid (µg)

Trial 1

Trial 2

Trial 3

Average

pRnLuc

5

168

205

204

192

pTUBRnLuc

5

15072

10311

15190

13524

p2.5kbSSRnLuc

5

441

413

245

366

Next, the activity of TUB promoter was compared to putative 2.5-kb SS promoter.
Both promoters are approximately the same in length (~2.5-kb), thus differences in activity
would be result from differences in sequences. The activity of different dilutions of TUB
promoter plasmid were compared to 5 µg of putative 2.5-kb SS promoter. As shown in
Figure 3.4, the activity of 2.5-kb SS is 100x-1000x lower than TUB activity.
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Figure 3.4
Relative Luciferase Activity of Putative 2.5-kb TgUlp1 mRNA
promoter Compared to Strong Tubulin Promoter
Relative RnLuc activity was measured and normalized to that of co-transfected FFLuc
activity. The green bar represents the activity of the 2.5-kb putative promoter on the sense
strand (5 µg). Gray bars represent the activity of TUB promoter in varying amounts and
black bars represent activity of no promoter (5 µg). Activity of the 2.5-kb sense putative
promoter was compared to 10-fold dilutions of the TUB promoter. Error bars represent
SEM (n = 3).
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3.2

Identifying TgUlp1 mRNA and NAT Promoters
With the promoter assay established, the next aim was to identify the sequence

controlling TgUlp1 mRNA and NAT expression. Promoter activity was measured in
tachyzoite and bradyzoite stages of T. gondii life cycle in both Type I and Type II strains
to determine if life stage or strain had any effect on promoter activity. RnLuc and FFluc
plasmids were electroporated into freshly lysed parasites, grown for 24 hours and then
collected to measure luciferase expression. Relative RnLuc/FFLuc activity of each putative
promoter was compared to the activity of no promoter as opposed to the highly active TUB
promoter. This allowed me to determine which putative promoter was significantly active.
In Type I tachyzoites (Figure 3.5 – solid bars), the 1.0-kb SS and the 2.0-kb AS
show a significant increase in RnLuc expression when compared to no promoter. The
promoter assay in Type II revealed that the same 1.0-kb SS and the 2.0-kb AS putative
promoters have high RnLuc expression (Figure 3.5 – dotted bars), however only the 2.0kb AS is statistically significant. Activity for all pPutPromRnLuc is similar between the
strains which indicates that strain differences do no affect TgUlp1 mRNA and NAT
promoter activity.
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Promoter Activity in Type I and Type II T. gondii Tachyzoites

Relative RnLuc activity was measured and normalized to that of co-transfected FFLuc
activity. Green bars represent activities of sense strand promoters, red bars represent
activities of antisense strand promoters and black bars activities of represent no promoter.
Solid bars represent activity in Type I, and dotted bars represent activity in Type II. The
1.0-kb region on the sense strand and 2.0-kb region on the antisense strand have the highest
RnLuc expression when compared to no promoter in both Type I and Type II. Error bars
represent SEM (n = 3). *P < 0.05; compared to no promoter control, unpaired two-sided ttest.
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3.3

TgUlp1 mRNA and NAT Promoter Activity in Bradyzoites
Immunofluorescence assay was performed to confirm both Type I and II strains

ability and efficacy to convert to bradyzoites. Culturing the infected HFF monolayers under
a high pH (~8) and low CO2 (0.05% atmospheric level) is commonly used to convert
tachyzoites to bradyzoites [54]. Tachyzoites were allowed to infect confluent HFF
monolayers. After 6 hours, the media was changed to alkali conditions to allow conversion
for another 24 hours. Cells were fixed and stained with FITC-conjugated Dolichos biflorus
lectin (Dol-FITC). Dol-FITC labels the cyst walls that is specific to the bradyzoite life stage
of the parasite. As shown inFigure 3.6, cyst walls were detected within 24 hours with both
Type I and Type II parasites.
To evaluate whether the putative promoters were active under alkali growth
conditions, the promoter assay was performed in Type I bradyzoites after 24 hr incubation
in alkali media. Figure 3.7 shows that the 1.0-kb SS and 2.0-kb AS region have the highest
activity for RnLuc expression. However, only the 2.0-kb AS promoter is significant when
compared to no promoter. Due to the high similarity in promoter activity between in Type
I and II tachyzoites, it was assumed that Type I and II bradyzoites would also have a similar
pattern of activity.
Bases on these promoter assays, the promoter for TgUlp1 mRNA was identified to
be located within the 1.0-kb SS region upstream from exon and the promoter for TgUlp1
NAT was identified to be located within the 2.0-kb AS region located downstream from
intron 9. Their activities by promoter assay indicates that both sense and antisense
promoters are active in tachyzoites, but only the antisense promoter is active in bradyzoites.
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Hz

Dol-FITC

Hz/Dol-FITC

Type I

Type II

Figure 3.6
gondii.

Immunofluorescence Assay of Cyst Formation in Type I and II T.

Tachyzoites were used to infect confluent HFF monolayers. After 6 hours, the parasites
were grown under alkali conditions for another 24 hours then stained with Hoechst (Hz)
and a cyst-specific FITC conjugated lectin (Dol-FITC). Slides were microscopically
examined for bradyzoite conversion indicated by the presence of a cyst wall. Scale bars
represent 10 μm.
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Figure 3.7
Relative activity of RnLuc Under the Control of Putative Promoters in
Type I T. gondii Bradyzoites.
Relative RnLuc activity was measured and normalized to that of co-transfected FFLuc
activity. Green bars represent activities of sense strand promoters, red bars represent
activities of antisense strand promoters and black bars represent activities of no promoter.
The 2.0-kb region on the antisense strand shows significant increase in RnLuc expression
when compared to no promoter. Error bars represent SEM (n = 3). *P < 0.05; compared to
no promoter control, unpaired two-sided t-test.
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Our next aim was to investigate the pattern of expression when the identified
promoters of TgUlp1 mRNA and NAT were analyzed over longer incubation in alkali
media. Type II was used for further study in bradyzoites due to their ability to switch to
bradyzoite more easily and higher clinical relevance. Type II parasites were switched to
alkali media 6 hours after electroporation and incubated in alkali media for 24hr, 48hr and
72 hr before being collected for the dual luciferase assay. As shown in Figure 3.8, the sense
promoter activity decreases slightly but does not show any significant changes over time.
The antisense promoter shows a steep decrease in activity at 24 hours which remains
consistent up to 72 hours.
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Figure 3.8
Change in Sense and Antisense Promoter Activity in Type II
Bradyzoites
Relative RnLuc activity was measured and normalized to that of co-transfected FFLuc
activity. Solid bars represent expression of the promoters in tachyzoites (Tz) and striped
bars represent expression of the promoters after incubation in alkali media. Error bars
represent SEM (n = 3).
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3.4

TgUlp1 mRNA and NAT Expression
The promoter assay suggested that transcription of TgUlp1 mRNA and NAT is

differentially regulated between tachyzoites and bradyzoites. To further confirm this, RTqPCR was performed in Type II parasites to determine the level of TgUlp1 mRNA and
NAT expression. Total RNA was collected from freshly lysed parasites for tachyzoite
samples, and after incubation in alkali media for 24 hours for bradyzoite samples. Both
TgUlp1 mRNA and NAT were detected in tachyzoites. After conversion to bradyzoites,
TgUlp1 mRNA was detected to be 10x lower but TgUlp1 NAT was 60x higher (Figure
3.9).
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mRNA
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Figure 3.9

Bz

Expression of TgUlp1 mRNA and NAT in Tachyzoites and Bradyzoites

Bradyzoite samples were collected after growing for 24 hours in alkali media. The cDNA
reaction mixtures were diluted 1/1000 dilution for tachyzoite samples and 1/10 dilutions
for bradyzoite samples. Relative TgUlp1 mRNA and NAT expression levels in comparison
to GAPDH expression levels were measured and calculated using 2-ΔΔCt protocol. RTqPCR were analyzed using both biological and technical triplicates. Error bars represent
SEM.
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3.5

The Effect of TgUlp1 NAT on Gene Expression
3.5.1

Structural Analysis of TgUlp1 NAT

It has been hypothesized that TgUlp1 NAT is a precursor for short regulatory RNAs
belonging to miR60 family [53], which are capable of regulating the expression of TgUlp1
mRNA expression. The RNA structure prediction algorithm Mfold [55] was used to
generate secondary structures for a further analysis of TgUlp1 NAT as the substrate of
Dicer. Being the key enzyme of RNAi, Dicer recognizes hairpin (stem-loop) structures of
transcripts and cleaves them to yield short double-stranded RNA products of approximately
21-23 bps with 3’-overhang to guide RNA-silencing complexes. Based on the most stable
predicted structure shown in Figure 3.10, various locations with hairpin structures could
serve as the substrates to produce miRNA. The sequences of the hairpin structures are
shown in Table 3.2. The sequence from the potential miRNA were used to predict
interactions with the sense transcript. For example, hairpin #1 will give a miRNA product,
whose upper strand can recognize TgUlp1 transcript at the nucleotides +4786 to +4806 in
the intron 2. The lower strand can recognize TgUlp1 transcript at the nucleotides +2809 to
+2828 in the intron 2.
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#1
#2

#3

Figure 3.10

TgUlp1 NAT Structure Prediction

Predicted secondary structure of TgUlp1 NAT using Mfold. It contains many hairpin loops
(indicated by black arrows) that maybe processed by Dicer to generate miRNA.
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Table 3.2

Stem Loops Predicted to be Cleaved by Dicer

Yellow highlights indicate Watson-Click base pairing, and green highlights indicate
wobble (G:U) pair. Green and red bases are from step loop and black bases are from
TgUlp1 transcript.
Stem Loop Sequence

Matches on TgUlp1 Locus
Exon 1
+2809 to +2828
5’ CTCCTCAGCCTTCGCGTCTT 3’
3’ ACGACGCCAAGGGUCAACAG 5’
Intron 2
+4786 to +4806
5’ TTCTGCGAGAAAAACGAAAGA 3’
3’ AAGAAGGUCCACUGGCAUUGU 5’
Intron 2
+5183 to +5203
5’ TTTTTCTACGCGCGCGTCAGA 3’
3’ AAGAAGGUCCACUGGCAUUGU 5’
Intron 3
+5635 to +5655
5’ CTCTCCTAGGTGAGCATCAGC 3’
3’ AAGAAGGUCCACUGGCAUUGU 5’

Hairpin #1 (45nts)

AGAA
5’ UGUUACGGUCACCUGGA
G
||:| |||| || |
G
3’ ACGACGCCAA GGGUCAACAGAG
ACAG

Intron 6
+7051 to +7070
5’ CTCTTTACCCTTGGTCTGGC 3’
3’ ACGACGCCAAGGGUCAACAG 5’
Intron 6
+7096 to +7116
5’ TGGTTCTGCAGGAGCGTAACA 3’
3’ AAGAAGGUCCACUGGCAUUGU 5’
Exon 8
+7771 to +7791
5’ TTCTTCTACGCGAAGCTGACG 3’
3’ AAGAAGGUCCACUGGCAUUGU 5’
Exon 9
+8237 to +8256
5’ CACTGGACTCTCGGCGTCGT 3’
3’ ACGACGCCAAGGGUCAACAG 5’
Intron 9
+8275 to +8295
5’ TGGATCCACGTGACAGTTTCT 3’
3’ AAGAAGGUCCACUGGCAUUGU 5’
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5’-Flanking
+2061 to +2080
5’ AAAAAACGGCCTTTCCCGTG 3’
3’ UUUCAUGCAAGUAAGAGCAG 5’
Hairpin #2 (46 nts)

Intron 1
+4079 to +4098
5’ ATCTTTCCTTCCTTCTCGCC 3’
3’ UUUCAUGCAAGUAAGAGCAG 5’

U G
5’ GACGAGAAUGAACGUACUUU
:||:|||| |||| ||:|
3’ UUGUUCUUCGUUGCGCGAGA

U
C
C

Intron 5
+6552 to +6571
5’ CCTCTACTTTCATGCTCGTC 3’
3’ UUUCAUGCAAGUAAGAGCAG 5’

C C

Intron 6
+7073 to +7092
5’ ACATTTCCGTCCTTCTTGTC 3’
3’ UUUCAUGCAAGUAAGAGCAG 5’

5’-Flanking
+2149 to +2172
5’ GAATTTTCCCTTCTCTTGTCCTGG 3’
3’ CUGCCACGGAAAGAGAACGAGCUC 5’

Hairpin #3 (57 nts)

C
5’ CUCGAG CAA GAG AAAG GCACCGUC
C
||||||
|||
:|||| ||
G
3’ GAGCUCA
GCUC
UGUGG AG
A
CAG
ACAGACA
C

Intron 9
+8410 to +8433
5’ TGGGGTGTCTTGCCCTTACTGCAG 3’
3’ CUGCCACGGAAAGAGAACGAGCUC 5’
Intron 12
+9573 to +9596
5’ GATGGTGAGTGTCTTTTGCGGGTG 3’
3’ CUGCCACGGAAAGAGAACGAGCUC 5’
3’-Flanking
+10614 to +10641
5’ TCGATCTGCCGCGTGTCTCTTCTCCT 3’
3’ AGGUGUACAGACACUCGGACACUCGA 5’
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3.5.2

NAT and its Derivatives on the Expression of RnLuc Transcripts

A dual reporter system was used to determine if TgUlp1 NAT and its derivatives
have a regulatory effect. For this study, both of the reporter plasmids constitutively and
individually express FFLuc or RnLuc under the control of TUB promoter to ensure a high
level of expression. While the FFLuc activity serves as an internal control for
transformation efficiency and expression level, the RnLuc activity will reflect the
regulatory effect of TgUlp1 NAT and its derivatives. The RnLuc transcripts were
engineered to carry various portions of TgUlp1 mRNA containing predicted miRNA
binding sites (25 nts), referred to as site A or B (Figure 3.11). These miRNA binding sites
were placed at the 3’-UTR of the RnLuc transcript. Both constructs were electroporated
along with single stranded NAT (ssNAT) and ssNAT digested with RNase III (NAT-R).
NAT-R was confirmed to produce short RNA using gel electrophoresis. It was observed
that ssNAT was able to lower RnLuc expression by 55 ± 2.4% and 40 ± 1.8% for constructs
A and B respectively (Figure 3.12). NAT-R was also able to lower RnLuc expression by
47 ± 1.2% and 41 ± 1.6% for constructs A and B respectively.
The promoter assay suggests that both TgUlp1 mRNA and NAT transcription is
active in tachyzoites. Thus, it is possible that TgUlp1 mRNA and NAT form dsRNA which
may confer a regulatory effect on TgUlp1 mRNA expression. To test this, we
electroporated constructs A and B with long double stranded NAT (dsNAT, 1167bps). In
Figure 3.12, we see that dsNAT did not have an effect on RnLuc expression.
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Predicted mRNA Binding Site Sequence

Location on TgUlp1 mRNA

5’ CGUCCUGGACACAAGGACGACUAUCU 3’

Exon 1/2 Junction
(+1165 to +1190)
(Site A)

5’ UGCCAUGCAUGGAAAGAAAUGUGUG 3’

3’ Flanking Region
(+2700 to +2725)
(Site B)

Figure 3.11 Predicted Binding Sites on TgUlp1 mRNA Used To Detect SelfRegulation By TgUlp1 NAT
Two sequences on the TgUlp1 mRNA were tested for self-regulation. Site A is in the CDS
spanning the exon 1/2 junction (+1165 to +1190). Site B is in the 3’-UTR (+2700 to
+2725). The sites were cloned downstream of the RnLuc CDS in pTUBRnLuc so that the
3’-UTR of the RnLuc transcript would carry the either Site A or B sequences. These
constructs were used in a dual luciferase assay.
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Effect of TgUlp1 NAT on Engineered RnLuc Expression

Relative RnLuc activity was obtained and normalized to that of co-transfected FFLuc
activity. Construct A and B were electroporated with and without 5 µg of in vitro
transcribed single stranded (ss), double stranded (ds) or RNase III Digested (-R) TgUlp1
NAT to determine its’ effect on RnLuc expression. pTUBRnLuc (no site) was used to
establish basal RnLuc activity without any binding sites. ssNAT and NAT-R were able to
lower the expression of both constructs RnLuc carrying predicted miRNA binding sites
from TgUlp1 mRNA. Error bars represent SEM (n = 3). *P < 0.05; compared to no RNA,
unpaired two-sided t-test.
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3.6

Effect of TgUlp1 NAT on the level of TgUlp1 mRNA
The dual luciferase assay suggested that TgUlp1 NAT could be a precursor for

miR60 family that regulates the expression of RnLuc transcripts. To determine the effect
of TgUlp1 NAT on the expression of mRNA, ssNAT was electroporated into Type II
parasites and mRNA expression was measured by RT-qPCR. Figure 3.13 describes the
experiment flow. Lysed parasites were electroporated with (+) and without (mock, -)
ssNAT. RNA samples were collected after 24 hours to determine the immediate effect of
ssNAT. Parasites were subcultured twice, and RNA was collected after each subculture to
observe changes in TgUlp1 mRNA expression. In Figure 3.14, we observed that after mock
electroporation, mRNA level dropped approximately 10x and stayed consistently low for
120 hours post electroporation. When ssNAT is electroporated, mRNA expression is
unaffected compared to mock (Figure 3.14). We also measured TgUlp1 NAT level after
mock electroporation. In Figure 3.15, we see mock electroporation caused an increase NAT
expression by approximately 10x which is consistent for 120 hours post electroporation.
Due to the changes in TgUlp1 mRNA and NAT level caused by electroporation process
itself, we were unable to determine if NAT had an effect on the level of TgUlp1 mRNA.
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Experiment Flow for Detecting Effect of in vitro NAT

Lysed parasites were electroporated with (+) and without (mock, -) ssNAT. RNA samples
were collected after 24 hours to determine the immediate effect of ssNAT. Parasites were
subcultured twice, and RNA was collected after each subculture to observe changes in
TgUlp1 mRNA expression. Tz refers to tachyzoites and EP refers to electroporation.
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Striped bar represents mRNA expression after mock electroporation and solid bars
represent mRNA expression after in vitro NAT electroporation. Relative TgUlp1 mRNA
expression levels in comparison to GAPDH expression levels were measured and
calculated using 2-ΔΔCt protocol. RT-qPCR were analyzed using both biological and
technical triplicates. Error bars represent SEM.
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Figure 3.15

TgUlp1 mRNA and NAT Expression After Mock Electroporation

Striped green bar represents TgUlp1 mRNA expression after mock electroporation and
striped red bars represent TgUlp1 NAT expression after in vitro NAT electroporation.
Relative TgUlp1 mRNA and NAT expression levels in comparison to GAPDH expression
levels were measured and calculated using 2-ΔΔCt protocol. RT-qPCR were analyzed using
both biological and technical triplicates. Error bars represent SEM.
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3.7

TgUlp1 mRNA and NAT Expression in TgDicer-KO and TgAgo-KO
To further evaluate whether RNAi is involved in the expression of TgUlp1 mRNA

and NAT, RT-qPCR analysis was performed in TgDicer-KO and TgAgo-KO strains.
TgDicer-KO was created by a previous student by inserting the YFP HX gene in frame
with the TgDicer gene. TgDicer-KO is incapable of digesting lncRNA, such as the
hypothesized TgUlp1 NAT. TgAgo-KO was created by replacing the entire TgAgo gene
with hypoxanthine-xanthine guanine phosphoribosyl transferase (HXGPRT) as a
selectable marker. TgAgo-KO strain has reduced gene silencing ability. RT-qPCR
performed show that TgUlp1 NAT levels is approximately 7x higher in both KO strains
compared to its parental strain. TgUlp1 mRNA levels in both KO strains are approximately
10x lower (Figure 3.16).
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Figure 3.16 TgUlp1 mRNA and NAT expression in TgDicer-KO and TgAgo-KO
compared to its’ parental
Relative TgUlp1 mRNA and NAT expression levels in comparison to GAPDH expression
levels were measured and calculated using 2-ΔΔCt protocol. RT-qPCR were analyzed using
both biological and technical triplicates. Error bars represent SEM.
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CHAPTER 4 – DISCUSSION
4.1

Promoters for TgUlp1 mRNA and NAT
To establish the promoter assay, we used the highly expressed β-tubulin (TUB)

promoter controlling the activity of the RnLuc reporter in setting an upper limit of
detection, and the RnLuc construct without a promoter in setting a lower limit of
background detection. There are multiple advantages for using RnLuc and FFLuc. First,
the assay is highly reliable. Both enzymes are stable for more than one hour while providing
a luminescent signal using independent substrates: coelenterazine for RnLuc and Dluciferin for FFLuc. Second, both enzymes have a linear range covering eight orders of
magnitude, which allows for the detection of approximately 0.1 femtogram (approximately
10–21 mole) of enzyme [56]. Therefore, the assay provides highly sensitive measurement
of gene expression analysis. The reliability, stability and sensitivity of dual luciferase
assays have allowed us to establish an assay to identify the promoters for TgUlp1 mRNA
and NAT.
In eukaryotes, two core components constitute a functional promoter. These DNA
sequences often referred to as core promoter and proximal promoter [57]. The core
promoter contains the RNA polymerase binding site, TATA box, and transcription start
site (TSS). The proximal promoter contains sequences that bind transcription factors and
is found approximately 250-bps upstream from the TSS. The sequences and locations of
these promoter elements contain a certain degree of conservation. Therefore, mapping and
functional analysis are essential in gaining a better understanding of these elements. To
study the promoter controlling the expression of TgUlp1 mRNA and NAT, we began by
choosing an arbitrary 2.5-kb region upstream from exon 1 to map the putative promoter
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controlling TgUlp1 mRNA, and 2.5-kb region downstream from intron 7 to map TgUlp1
putative promoter controlling TgUlp1 NAT. Starting with the 2.5-kb 5’-flanking region of
TgUlp1 locus as the expression of TgUlp1 is well characterized (Figure 3.1), we compared
the activity of this region to TUB promoter and found that the putative TgUlp1 mRNA
promoter activity was 100x-1000x lower. This expression level agrees with microarray
analysis

published by ToxoDB for

TgUlp1 (TGGT1_2144700) and TgTUB

(TGGT1_266960), as TgUlp1 is shown to express at a lower level than TUB [58]. Further
mapping of the region identified the promoter for TgUlp1 mRNA to be the 1.0-kb region
upstream from exon 1 on the sense strand. Although it is shorter than the TUB promoter
we used, it agrees with the minimal and function promoter controlling TUB [59]. The
promoter of TgUlp1 NAT was identified to be the 2.0-kb region between from intron 9
(+5768) to 3’-flanking region (+7920) on the antisense strand (Figure 4.1).
So far, well-characterized motifs such as TATA box have not been observed in T.
gondii core promoters [60]. However, there is evidence that other motifs are important for
transcription in T. gondii such as the initiator element (Inr). Inr is a core promoter,
commonly found in genes that lack TATA box and the most common sequence found at
the TSS of eukaryotic genes [61]. Using ElemeNT, we identified Inr in the promoter for
TgUlp1 mRNA and NAT (Table B6). We can also identify other important motifs such as
GAGACG and TGCATGC in the identified promoter for TgUlp1 mRNA and NAT as
shown in Table B7 and Table B8. GAGACG has been identified as a critical element in
many T. gondii promoters [62]. In fact, it has been suggested that this motif might be the
T. gondii equivalent to TATA box seen in other eukaryotes [32]. TGCATGC is the
putative binding motif for apicomplexan AP2 (ApiAP2) family of transcription factors and
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conserved in other members of the apicomplexan phylum including T. gondii [63]. This
motif is found in hundreds of T. gondii promoters. Inr, GAGACG, and TGCATGC motifs
were found almost exclusively within the identified promoter regions for TgUlp1 mRNA
and NAT.
TgUlp1 NAT 2.0-kb promoter exhibits the highest RnLuc activity but is not
immediately upstream from intron 7 of the antisense transcript detected, as shown in Figure
4.1 [53].
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Figure 4.1

Identified Promoters of TgUlp1 mRNA and NAT

Green and red bar represents the promoter region for TgUlp1 mRNA and NAT
respectively. Green and red arrows represent the transcription of TgUlp1 mRNA and NAT
respectively. * indicates a 500-bps region between the detected TgUlp1 NAT and its
identified promoter.

Two possible explanation to this finding are: one, this 500-bps region, indicated by a star
(Figure 4.1), contains regulatory elements such as silencers which can bind repressor
proteins to negatively regulate transcription. To characterize this controlling elements, one
can perform mutation analysis of the nucleotide sequence of the region. A dual luciferase
assay, such as those used in the study, can be modified for the study. The second
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explanation is due to our lack of information on the TSS features. Currently the full length
of TgUlp1 NAT has not yet been characterized, and its 5’-end could start in within this
starred region. For future work, one can map the 5’-end of TgUlp1 NAT by using a
technique called primer extension [64]. This technique requires a radiolabeled primer
complementary to a region on the transcript. The primer anneals to the transcript and
reverse transcriptase is used to synthesize cDNA until it reaches the 5'-end of the transcript.
The transcript-cDNA hybrid is denatured, and cDNA product is analyzed on a sequencing
gel. Rapid amplification of cDNA ends (RACE) is another technique that can be used to
obtain the full length sequence of a transcript [65]. Similar to primer extension, this
technique generates cDNA using a gene specific primer and reverse transcriptase. After
first strand cDNA synthesis, the original transcript template is treated with RNase and an
oligonucleotide adapter is linked to the 3’-end of the cDNA. Thereafter, PCR is performed
using a gene specific primer and primer for the adapter to amplify the region with the 5′
unknown sequence. PCR products are then cloned into a vector for sequencing.
4.2

Expression Of TgUlp1 mRNA And NAT During Its Asexual Cycle
T. gondii pathogenicity comes from its ability to differentiate between tachyzoites

and bradyzoites to evade the host immune response. Thus, a better understanding of the
molecular mechanisms that drive stage conversion between tachyzoites and bradyzoites is
necessary to manage transmission and pathogenesis of T. gondii. Many studies have
documented genes that are exclusively expressed in either tachyzoites or bradyzoites,
suggesting that different expression of gene play a major role in coordinating transitions
in T. gondii [66]. However, studies in differential regulation in T. gondii have focused on
protein-coding genes. In this study, I focus on antisense gene regulation and observed that
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TgUlp1 NAT is differentially regulated at the transcriptional level. In tachyzoites, both
identified promoters are active which indicates TgUlp1 mRNA and NAT transcription may
be occurring at the same time. This was further confirmed by RT-qPCR which detects the
presence of both sense and antisense transcripts in tachyzoites. In bradyzoites we observe
a lower sense promoter activity bradyzoites in agreement with lower TgUlp1 mRNA
expression. However, despite a decrease in antisense promoter activity, RT-qPCR shows
us that TgUlp1 NAT expression is higher in bradyzoites compared to tachyzoites. This
indicates that although antisense promoter might be less active in bradyzoites, the antisense
transcript turnover is slower. In addition, time course experiment showed no change in
promoter activity with longer incubation in alkali conditions. Taken together, the promoter
assay and RT-qPCR suggested that the expression of TgUlp1 NAT and mRNA are
differentially regulated at the transcriptional and post- transcriptional level via promoter
activity and transcript turnover.
Although the promotor assay has been useful in discriminating between active and
nonactive promoter sequences, the discrepancy between promoter activity and transcript
suggested other mechanisms are involved. For example, differences in transcript stability
between TgUlp1 mRNA and NAT and RnLuc would affect our measurements for promoter
activity. In addition, distal regulatory elements and chromatin modification are a common
feature of the eukaryotic genome which are responsible for transcriptional regulation [67].
In a reporter system, the promoter is stripped of this genomic context which may lead to
non-specific promoter activity.
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4.3

TgUlp1 NAT and its Regulatory Effect
ncRNA molecules have generally been discovered by large-scale sequencing

projects that were carried out for various model organisms, such as humans, mice and
worms. Similarly, large-scale sequencing projects of Apicomplexan parasites have
confirmed the presence of long and short ncRNAs, including NATs and miRNA [30, 31].
However, the discovery of TgUlp1 NAT was fortuitous. During the study of TgUlp1
mRNA as a potential target of miR60 family, NAT was discovered by gene specific RTPCR [53]. The fact that TgUlp1 is the first gene confirmed as the target of miR60 family
led us to hypothesize that TgUlp1 NAT, as a lncRNA species, is a regulatory RNA. To test
this hypothesis, we adopted two strategies. One was an in silico analysis of TgUlp1 NAT
as the precursor of miRNAs. The analysis of TgUlp1 NAT showed several potential
miRNAs whose sequence are highly complementary to TgUlp1 mRNA (Table 3.2).
Our second strategy was to use a dual luciferase system in determining the
regulatory effect of TgUlp1 NAT (ssNAT) and its RNase-III digested products (NAT-R).
To create the reporter transcript for this experiment, we placed the sequence of predicted
binding site at the end of RnLuc CDS and in the 3’-UTR. Such a reporter construct is
commonly used in the study of siRNA and miRNA silencing function [68, 69]. We detected
that ssNAT and NAT-R were able to downregulate RnLuc expression. This indicates that
as a lncRNA, TgUlp1 NAT could yield short regulatory ncRNAs. It is highly likely that
the short regulatory ncRNAs have the structural features of miRNAs. It should be noted
that these short regulatory ncRNAs were previously shown to have similar down-regulation
effect as those of miR60 family [53]. As both sense and antisense promoters are active in
tachyzoites, it is also possible that both transcripts could form perfect-paired double-
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stranded RNA that could affect the regulation of TgUlp1 mRNA. However, we did not
detect that the long double-stranded RNA of NAT (dsNAT) has silencing activity. It would
be interesting to further test whether the RNase III products of long double-stranded RNA
of NAT can exhibit similar activity as those of ssNAT and NAT-R. Consequently, it would
imply that TgUlp1 NAT and its counter mRNA form dsNAT and serve as a siRNA
precursor.
When we analyzed the predicted secondary structure of TgUlp1 NAT, we found
multiple stem loops that could be substrates for Dicer. We analyzed the predicted products
against mRNA and found multiple sites which may be targeted by TgUlp1 NAT derivatives
to regulate expression. To identify if the loops we predicted were actually miRNA
precursors, one can perform northern blot of in vitro NAT-R products. By probing for the
stem loop sequences predicted as Dicer cleavage sites, we can confirm if TgUlp1 NAT
produces short regulatory RNA. In addition, one can sequence NAT-R products and look
for a match on the TgUlp1 transcript. If a match between the sequenced NAT-R products
and TgUlp1 transcript is found, it will provide a more specific and likely target to test for
self regulation of TgUp1. To determine if Dicer is involved in processing TgUlp1 NAT
endogenously, one could also perform northern blot in TgDicer-KO and probe for TgUlp1
NAT.
Since ssNAT and NAT-R were able to downregulate the expression of RnLuc
carrying predicting binding sites derived from the TgUlp1 mRNA, we speculated that
TgUlp1 NAT would directly affect the level of TgUlp1 mRNA. However, we are unable
to conclude if TgUlp1 NAT has a direct effect on mRNA levels. Instead, we observed that
the stress of electroporation alone affected TgUlp1 transcript levels; mRNA level
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decreased, and NAT levels increased and remained consistent up to 120 hours. This
indicated TgUlp1 NAT may play a role in the parasite’s stress response. To further study
the effect and role of TgUlp1 NAT in the response, one can alter the expression of TgUlp1
NAT by repressing the transcription of TgUlp1 NAT using CRISPR interference
(CRISPRi) [70]. This repurposed CRISPR/Cas9 system requires an inactive version of
Cas9 (dCas9) which was created by two point mutations in its RuvC-like (D10A) and HNH
nuclease (H840A) domains [71]. These mutations allow dCas9 to bind double stranded
DNA, but it no longer has endonuclease activity. Directed by a single guide RNA, the
dCas9 will bind at the promoter we identified by the dual luciferase assay. Once bound, it
would interfere with transcription initiation and lead to TgUlp1 NAT knockdown.
Interrupting the expression of TgUlp1 NAT will allow us to measure its effect on the
mRNA by RT-qPCR. If TgUlp1 NAT is essential to the regulation of TgUlp1, we would
expect to see change in mRNA levels when NAT decreases. Previous studies using
CRISPRi show that this system is good for studying overlapping transcription units [71],
such as in the case of TgUlp1 mRNA and NAT. Traditional knockdown methods such as
a RNAi have several limitations. First, knocking down antisense transcript require
exogenous siRNAs to carry sense transcript sequences. Second, unlike protein-coding
genes, many lncRNAs primarily localize in the nucleus. Even though RNAi machinery
has been found to be active in the nucleus, siRNAs against nuclear lncRNAs have often
proven to be less effective [71].
4.4

Dicer and Ago Knockout Strains of Toxoplasma gondii
Dicer and Argonaute are key ribonuclease of the silencing pathways mediated by

small ncRNAs, including siRNA and miRNA. Logically, if TgUlp1 NAT is a precursor

62

short regulatory ncRNA, it would depend on Dicer and Ago to regulate mRNA expression.
We expected to detect a higher expression of TgUlp1 mRNA in both knockout strains.
However, we detected that TgDicer-KO and TgAgoKO have a much lower level of TgUlp1
mRNA and a higher level of TgUlp1 NAT in comparison to the parental strain, indicating
that Dicer and Ago are involved in maintaining TgUlp1 mRNA.
A study by Napoli et al., [72] looked at self-regulation of the oncogene c-MYC by
its NAT. They found that, the c-Myc NAT is processed by Dicer to produce short regulatory
RNA and that Dicer knockdown resulted in a lower mRNA level and higher NAT level.
They speculated that because DICER is also involved in chromatin modifications, c-Myc
sense and antisense transcripts were regulated by altering the chromatin state. To test this,
they treated Dicer knockout cells with HDAC inhibitor which induced acetylation of
histones at c-Myc locus, further reducing mRNA and increasing NAT levels. This provides
evidence that altering chromatin states regulate c-Myc NAT transcription, which in turn
may negatively regulate c-Myc mRNA expression. Although my study did not look at
epigenetic regulation of TgUlp1 NAT, studying this relationship would provide more
insight on antisense regulation in T. gondii.
Interestingly, we see a very similar pattern of expression for TgUlp1 mRNA and
NAT when we compare RT-qPCR results between bradyzoites, mock electroporation,
TgDicer-KO, and TgAgoKO. In each experiment, there was a higher level of TgUlp1 NAT
and lower level of mRNA. This suggests that TgUlp1 NAT may play a role with managing
the parasites stress response. Previous work in studied the relationship between bradyzoite
and Ago and found that knockout of Argonaute expression resulted in an increase in
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bradyzoite formation [73]. This suggests that RNAi and TgUlp1 NAT play a role in
bradyzoite formation.
RT-qPCR shows a drastic decrease in TgUlp1 mRNA level following stress and
during bradyzoite life stage. Consequently, this would also affect TgUlp1 protein levels
and ultimately the SUMOylation pathway in T. gondii. Previous work provides evidence
that SUMOylation plays an important role in host cell invasion and cyst genesis [52]. If
TgUlp1 NAT does regulate mRNA expression, it will provide more insight into the role of
NAT in gene expression and pathogenesis in T. gondii. In addition, studies in other
organisms provide evidence that NAT also exert their function in a trans-acting manner.
Therefore, in addition to the cis-acting mechanism hypothesized and tested in this study,
TgUlp1 NAT may also function in trans to regulate gene expression through various ways.
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CONCLUSION
NATs are widespread in eukaryotes and are being recognized as important
regulators of gene expression. Although NATs are a common feature in Apicomplexan
transcriptome, very little is known about their regulation, function, or its implications in
cell biology. A NAT species was fortuitously discovered during the study of TgUlp1
mRNA as a potential target of miR60 family. Studying the mechanisms controlling the
function of TgUp1 NAT will provide more insight on the role NATs play in T. gondii.
The objective of this study was to identify the elements controlling the expression
of TgUlp1 NAT and elucidate its mechanism of function. Using a dual luciferase assay, we
identified the promoter controlling the transcription of TgUlp1 mRNA and NAT. Although
lacking a TATA box, the identified promoters contain many motifs that have been
identified in T. gondii promoters as important for initiating transcription. Further work
revealed that the promoters for TgUlp1 mRNA and NAT are active in tachyzoites but only
NAT promoter is active in bradyzoites. RT-qPCR showed TgUlp1 mRNA was lower, but
TgUlp1 NAT higher in bradyzoites compared to tachyzoites. Taken together, the data
suggests that the expression of TgUlp1 NAT and mRNA are differentially regulated at the
transcriptional level, via promoter activity and transcript turnover. Furthermore, this
implies stage-specific expression of transcripts and therefore may provide insight on the
role NATs have in tachyzoite-bradyzoite differentiation.
TgUlp1 is the first gene confirmed as the target of miR60 family, which led us to
hypothesize that TgUlp1 NAT is a regulatory RNA. Using a dual luciferase, we observed
that when TgUlp1 NAT was in vitro processed by RNase III, the products retain the ability
to lower the expression of engineered reporters carrying TgUlp1 mRNA sequences. This
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suggests the involvement of RNAi. To further evaluate whether the Dicer and Argonaute,
key enzymes in RNAi, are required for the processing and function of TgUlp1 NAT in vivo,
RT-qPCR analysis was performed in TgDicer-KO and TgAgo-KO. We observed a lower
level of TgUlp1 mRNA and higher level of TgUlp1 NAT in both strains compared to the
parental. This indicates that Dicer and Ago are involved in maintaining TgUlp1 mRNA,
We were unable to determine if in vitro TgUlp1 NAT had a direct affect on mRNA but did
observe that electroporation alone caused decrease in mRNA and increase in NAT levels.
The similar transcript levels between bradyzoites and mock electroporation suggest that
TgUlp1 NAT may play a role in the parasite’s stress response. Consequently, these changes
in TgUlp1 mRNA and NAT levels would also affect TgUlp1 protein levels and ultimately
the SUMOylation pathway in T. gondii. Previous work in T. gondii show that
SUMOylation plays an important role in host cell invasion and cyst genesis. If TgUlp1
NAT does regulate mRNA expression, it would ultimately affect the parasites ability to
invade and form cysts. Therefore, studying the role of TgUlp1 NAT plays in the parasite
will provide more insight into the pathogenesis of T. gondii.
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APPENDICES
Appendix A

Figure A1

pTUBRnLuc

This diagram shows the plasmid coding for RnLuc under the control of TUB promoter. It
was used as a positive control in dual luciferase assays for both identifying promoters and
gene silencing. pTUBRnLuc was digested with NheI and HindIII to remove the tubulin
(TUB) promoter (2717bps). The linearized product was ligated to putative promoter
sequences that were amplified by PCR.
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Figure A2

pRnLuc

This diagram shows the plasmid coding for RnLuc without a promoter. It was used as a
negative control for background expression in dual luciferase assays for identifying
promoters.

Figure A3

Diagram Showing Primers Used for TgUlp1 RT-qPCR.

Schematic diagram of intron 6 to intron 8 from the TgUlp1 locus. Arrows indicate
location of primer binding site. Green arrows are TgUlp1 mRNA primers and red arrows
are TgUlp1 NAT primers used for RT-qPCR. Primer sequences are listed in Table B4.
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Appendix B
Table B1

Primers Used to Construct Plasmids For The Promoter Assay

Digestion sites are highlighted in red
Primer Name

Sequence

pr_RV_senseUlp1 (a)

caccttggaagccatgctagcggccacacgagaggggaaaag

pr_FW-senseUlp1 (b)

gtcgacggtatcgataagcttctgcatcggtttgcgcct

pr_FW-senseUlp1p1k (c)

gtcgacggtatcgataagcttcaaccgagcggtgctggc

pr_FW-senseUlp1p2.5k (d)

gtcgacggtatcgataagcttagagcagaagagggagcc

pr_RV_antisenUlp (e)

caccttggaagccatgctagcgaccttcttcttcaacac

pr_RV_antisenUlpAt1k (f)

caccttggaagccatgctagcgaggtgagacaatggatc

pr_FW-antisenUlp0.5k (g)

gtcgacggtatcgataagcttgatccattgtctcacctc

pr_FW-antisenUlp1k (h)

gtcgacggtatcgataagcttcgtttgcagaactttcgc

pr_FW-antisenUlp2k (i)

gtcgacggtatcgataagcttgaggtcaaatgaccacgg

Table B2

pPutPromRnLuc Used in the Promoter Assay
Promoter

Plasmid Name

0.5-kb SS

pRnpromoterUlp0.5k_SS

1.0-kb SS

pRnpromoterUlp1k_SS

2.5-kb SS

pRnpromoterUlp2.5k_SS

0.5-kb AS

pRnpromoterUlp0.5k_NAT

1.0-kb AS

pRnpromoterUlp1.0k_NAT

2.5-kb AS

pRnpromoterUlp2.5k_NAT

2.0-kb AS

pRnpromoterUlp2k_NAT
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Table B3

Primers Used to Make Templates For in Vitro RNA

T7 promoter sequence for in vitro transcription are highlighted in red
Primer Name

Sequence

TgUlp1intron6Fw

ggctgaacgacgaagttatc

TgUlp1intron7T7Rv

taatacgactcactataggaacagaggcgaagtcgtaggt

TgUlp1intron6T7Fw

taatacgactcactataggctgaacgacgaagttatc

Table B4

Primers Used for RT-qPCR

Primer Name

Sequence

RT_PCR Ulp1_Fw (j)

cgtaacaagaagcaacgcgc

RT_PCRUlp1_Rv (j')

cgaacagaggcgaagtcgta

qAntiUlp1Fw (k)

tgggcgaagacggagaaga

qAntiUlp1Rv (k')

ttccaggtgaccgtaacatgtg

qPCR_GAPDH_Fw

ggtgttccgtgctgcgat

qPCR_GAPDH_Rv

gcctttccgccgacaat

Table B5

Amount of Plasmid Electroporated Based on Experiment
Plasmid

µg

pRnLuc

5

p2.5kbSSRnLuc

5
5

Establishing
Promoter Assay

0.5
pTUBRnLuc

0.05
0.005
0.0005

In vitro NAT
Electroporation

pTUBRnLuc

5

pTUBRnLuc_SiteA

5

pTUBRnLuc_SiteB

5
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Table B6

Initiator Element Identified in TgUlp1 Promoters

Identified TgUlp1 sense and antisense promoter sequences were analyzed by ElemeNT for
Initiator Element (Inr), YYANWYY, where Y = C/T, W = A/T, N = A/C/G/T. Only
matches with PWM score >0.2 and complete consensus match are displayed.
TgUlp1
Promoter

Sequence

TgUlp1 Locus

PWM
Score

5’ TGCCACTTCTCGTTGCGTTC 3’
3’ ACGGTGAAGAGCAACGCAAG 5’

5’-Flanking
(-469 to -450)

1.0000

5’ GAGAGAAGTTGTCACATCTG 3’
3’ CTCTCTTCAACAGTGTAGAC 5’

5’-Flanking
-1019 to -1000

0.3636

5’ GCTTTGTCACTTTTCCCCTC 3’
3’ CGAAACAGTGAAAAGGGGAG 5’

5’-Flanking
-29 to -10

5’ TATGGGTCTGAGTCGCGCGT 3’
3’ ATACCCAGACTCAGCGCGCA 5’

Intron 9
(+6051 to +6070)

0.3410

5’ CTCGGATTGAGTGCCTCGCG 3’
3’ GAGCCTAACTCACGGAGCGC 5’

Intron 10
+6211 to +6230

0.6499

5’ TGTGGTTTGAAAGTCCCACT 3’
3’ ACACCAAACTTTCAGGGTGA 5’

Intron 10
+6511 to +6530

0.2954

5’ CATTGAAGAGTGGTGCATCC 3’
3’ GTAACTTCTCACCACGTAGG 5’

Exon 11
+6581 to +6600

0.6000

2.0-kb NAT 5’ GGGAAGTGAACAAGGACGGG 3’
3’ CCCTTCACTTGTTCCTGCCC 5’
Promoter

Intron 11
+6701 to +6720

0.8000

5’ GTGGGTGTGGAACCAGGTGT 3’
3’ CACCCACACCTTGGTCCACA 5’

Intron 11
+6881 to +6900

0.4545

5’ GGAGAGTGACAAGCGAAGAG 3’
3’ CCTCTCACTGTTCGCTTCTC 5’

3’-Flanking
+7441 to +7460

0.4800

5’ GAGAAAAAAGAATGAAGCAG 3’
3’ CTCTTTTTTCTTACTTCGTC 5’

3’-Flanking
+7501 to +7520

0.3600

5’ ACGAAGTGACACGGGCCGGG 3’
3’ TGCTTCACTGTGCCCGGCCC 5’

3’-Flanking
+7721 to +7740

0.8000

1.0-kb
mRNA
Promoter

0.4800
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Table B7

GAGACG Motif Identified in TgUlp1 Promoters

Sequence from identified TgUlp1 sense and antisense promoters were analyzed for
GAGACG motif using Vector VNTI.
TgUlp1
Promoter

Sequence

TgUlp1 Locus

1.0-kb
mRNA
Promoter

5’ AAGCGTGGAGACGCAGAGAA 3’
3’ TTCGCACCTCTGCGTCTCTT 5’

3’-Flanking
-229 to -210

5’ AGTCGCGCGTCTCGGTTCTC 3’
5’ TCAGCGCGCAGAGCCAAGAG 3’

Intron 9
+6061 to +6080

5’ GATCGTGTGCGTCTCGAGCG 3’
5’ CTAGCACACGCAGAGCTCGC 5’

Intron 10
+6421 to +6440

5’ TTTCGCGTCTCTTCGGTGAT 3’
3’ AAAGCGCAGAGAAGCCACTA 5’

Intron 10
+6451 t + 6470

5’ CTTTTGCTCGCGTCTCCGGA 3’
3’ GAAAACGAGCGCAGAGGCCT 5’

3’-Flanking
+7641 to +7660

2.0-kb NAT
Promoter

Table B8

TGCATGC Motif Identified in TgUlp1 Promoters

Sequence from identified TgUlp1 sense and antisense promoters were analyzed for
TGCATGC motif using Vector VNTI.
TgUlp1
Promoter

Sequence

TgUlp1 Locus

1.0-kb
mRNA
Promoter

N/A

N/A

5’ TCTCTGCATGCATATCGCTC 3’
3’ AGAGACGTACGTATAGCGAG 5’

Intron 9
+6011 to + 6030

5’ GGGAAGCATGCACAGAGAAG 3’
3’ CCCTTCGTACGTGTCTCTTC 5’

Intron 10
+6281 to +6300

5’ GCTTCCGCGCATGCAGGCTC 3’
3’ CGAAGGCGCGTACGTCCGAG 5’

Exon 13
+7381 to + 7400

2.0-kb NAT
Promoter
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